By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing
Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing
News

Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing

Last updated: 14/11/2025 11:36 PM
Published: 14/11/2025
Share
SHARE

BEIJING, Nov. 14, 2025 /PRNewswire/ — Token Cat Limited (Nasdaq: TC) today announced that, after divesting its long-term unprofitable business and completing organizational restructuring, the Company is accelerating its strategic expansion into high-technology and next-generation energy sectors. The Company’s U.S. subsidiary has now been authorized to evaluate a fundraising plan of up to $500 million to explore the potential application of nuclear fission energy in future computing infrastructure and to assess its feasibility as a long-term, stable power source for energy-intensive artificial intelligence operations.

- Advertisement -

The Company’s management noted that surging demand for AI and high-performance computing is creating unprecedented pressure on energy supply, stability, efficiency, and long-term costs. In this context, the Company views nuclear fission as a high-potential frontier and will study its trends, commercialization, and strategic fit through its U.S. subsidiary.

- Advertisement -

As part of this strategic initiative, the Company’s U.S. subsidiary plans to engage in deeper discussions with multiple research institutions, energy engineering firms, and AI computing infrastructure companies to explore potential collaboration opportunities. The goal is to develop a comprehensive research framework focused on advanced fission reactor technologies, small modular energy systems, and integrated nuclear-powered computing architectures.

- Advertisement -

Guangsheng Liu, Chief Executive Officer of Token Cat Limited, commented:

- Advertisement -

“AI’s growing energy demands are reshaping the global tech landscape. We see next-generation energy solutions as a key factor in future computing competitiveness. Through the U.S. subsidiary’s early-stage research, we aim to proactively assess the potential role of nuclear fission in next-generation computing infrastructure. We will pursue this strategy with both caution and ambition to secure a strong position in the coming technology cycle.”

- Advertisement -

Safe Harbor Statement

- Advertisement -

This announcement includes forward-looking statements under Section 21E of the Exchange Act and the U.S. Private Securities Litigation Reform Act of 1995. These statements, including those about the Company’s plans and outlook, are identified by terms such as “may,” “will,” “expect,” “anticipate,” “intend,” “believe,” and similar expressions. They are based on current expectations and involve risks and uncertainties, many outside the Company’s control. More information on these risks appears in the Company’s SEC filings. The Company assumes no obligation to update forward-looking statements except as required by law. 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/following-the-divestiture-of-loss-making-operations-token-cat-limited-authorizes-its-us-subsidiary-to-evaluate-a-potential–500-million-fundraising-plan-for-nuclear-fission-research-and-ma-to-address-the-growing-clean-energy–302615532.html

- Advertisement -
UN Global Compact Convenes First-Ever Dilemmas Forum to Tackle Strategic Challenges Facing Global Business
SANY Heavy Industry Lists on Hong Kong Stock Exchange, Marking New Milestone in Global Expansion with “A+H” Dual Listing
ADFW 2025 to Host Leaders Managing Capital Equivalent to Over 50% of Global GDP
BingX Listed as Approved VASP by Upbit Korea Under Travel Rule Framework
Via announces confidential submission of draft registration statement related to proposed public offering
TAGGED:500addressandauthorizescatcleancomputingdemanddivestitureenergyevaluatefissionfollowingforfundraisinggrowingitslimitedloss-makingm&amillionnewsnuclearoperationsplanpotentialResearchsubsidiarythetokenu.s.
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News

Milano Cortina 2026 and On Location unveil exclusive hospitality packages for the Olympic Winter Games

TheNews Market
TheNews Market
06/06/2025
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+ Company
HISTORIC 1800s WYOMING RANCH LEGACY TO SELL – CATO SOLDIER CREEK RANCH – SHERIDAN, HITS INTERNATIONAL MARKETPLACE
Ariceum Therapeutics Data at the 2025 European Association of Nuclear Medicine Annual Congress Further Supports the Advancement of 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer and Merkel Cell Carcinoma
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?